Cat Vaccine Global Market Report 2025

Description

A cat vaccine is a biological agent designed to safeguard cats from infectious diseases by activating their immune system to identify and combat specific pathogens. These vaccines use weakened or inactivated versions of viruses or bacteria responsible for diseases, which prompts the cat's immune system to generate antibodies without causing illness.

Ther main categories of cat vaccines are modified or attenuated live vaccines, inactivated vaccines, and others. Modified or attenuated live vaccines involve weakening the pathogen to prevent it from causing illness in cats. These vaccines address various diseases such as feline leukemia, feline panleukopenia, feline respiratory infections, and feline rabies. The available vaccine technologies include attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, and recombinant vaccines. They can be administered through different methods, including injections, intranasal, and oral routes. These vaccines are available through various channels, including veterinary clinics, pet stores, and online retailers.

The cat vaccine market research report is one of a series of new reports from The Business Research Company that provides cat vaccine market statistics, including cat vaccine industry global market size, regional shares, competitors with a cat vaccine market share, detailed cat vaccine market segments, market trends and opportunities, and any further data you may need to thrive in the cat vaccine industry. This cat vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cat vaccine market size has grown strongly in recent years. It will grow from $1.15 billion in 2024 to $1.26 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to rising emergence of new diseases in cats, increasing prevalence of animal diseases, increasing livestock population of animals, increasing population of companion animals, and increasing zoonotic diseases.

The cat vaccine market size is expected to see strong growth in the next few years. It will grow to $1.78 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to the rising trend of pet ownership, increasing disposable income, increasing demand for veterinary services, government and veterinary organization initiatives, and growing awareness of animal health among people. Major trends in the forecast period include development of advanced cat vaccines, innovative and more effective products, novel vaccine technologies, innovations in combination vaccines, and the development of personalized vaccinations.

The rise in zoonotic diseases is expected to drive the growth of the cat vaccine market. Zoonotic diseases are infections that can transfer from animals to humans through various pathogens such as bacteria, viruses, fungi, or parasites. These diseases can be transmitted via direct contact, vectors, or contaminated environments. Common zoonotic diseases include Lyme disease, rabies, toxoplasmosis, salmonellosis, and brucellosis. Factors contributing to the increase in zoonotic diseases include climate change, antibiotic resistance, and wildlife trade. Cat vaccines help manage these diseases by reducing the risk of transmission from cats to humans. For instance, they protect against diseases such as toxoplasmosis and cat scratch fever. By vaccinating cats, the impact of zoonotic diseases on human health is mitigated, supporting public health and creating a healthier environment for both pets and their owners. According to a February 2024 report from the Government of the United Kingdom, England saw 335 confirmed cases of Lyme disease in the fourth quarter of 2023, up from 273 cases in the same period in 2022. This increase underscores the growing demand for cat vaccines driven by rising zoonotic diseases.

Key players in the cat vaccine market are innovating with products such as NOBIVAC NXT vaccines, which use advanced Ribonucleic acid (RNA)-particle technology to boost immune responses and enhance vaccine effectiveness. This technology involves RNA molecules encased in nanoparticles that deliver genetic instructions to cells, prompting them to produce specific proteins that trigger a targeted immune response. For example, in June 2024, MSD Animal Health Inc. launched the NOBIVAC NXT Rabies portfolio, including NOBIVAC NXT Feline-3 Rabies and NOBIVAC NXT Canine-3 Rabies. These vaccines offer robust protection against rabies for cats and dogs without adjuvants or preservatives, improving safety while maintaining efficacy. They stimulate both humoral and cell-mediated immune responses for comprehensive protection against the rabies virus.

In September 2024, Boehringer Ingelheim Group, based in Germany, acquired Saiba Animal Health AG, a Switzerland-based company specializing in cat vaccines. This acquisition aligns with Boehringer Ingelheim's strategy to expand its portfolio and leverage Saiba's expertise in the field.

Major companies operating in the cat vaccine market are Merck & Co. Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., MSD Animal Health, Elanco Animal Health Incorporated, Intas Pharmaceuticals Ltd., Ceva Sante Animale, Virbac, Neogen Corporation, Indian Immunologicals Ltd., Jinyu Bio-technology Co. Ltd., Ourofino Animal Health SA, Biogenesis Bago SA, Valley Vet Supply , HIPRA Corporation, Bioveta AS, China Animal Husbandry Group, Veterinary Pharmaceutical Solutions, Torigen Pharmaceuticals Inc., KM Vet Pharm Sdn Bhd.

North America was the largest region in the cat vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cat vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cat vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cat vaccine market consists of sales of the bordetella vaccine, rabies vaccine, and feline immunodeficiency virus (FIV) vaccine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cat Vaccine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cat vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cat vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cat vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Vaccine Type: Modified Or Attenuated Live; Inactivated; Other Vaccine Types
2) By Disease Type: Feline Leukemia; Feline Panleukopenia; Feline Respiratory Diseases; Feline Rabies; Other Diseases
3) By Technology: Attenuated Live Vaccines; Conjugate Vaccines; Inactivated Vaccines; Subunit Vaccines; Toxoid Vaccines; Deoxyribonucleic Acid (DNA) Vaccines; Recombinant Vaccines
4) By Route Of Administration: Injectables; Intranasal; Oral
5) By Distribution Channel: Veterinary Clinics; Pet Stores; Online Retailers
Subsegments:
1) By Modified or Attenuated Live: Feline Viral Rhinotracheitis (FVR) Vaccine; Feline Calicivirus (FCV) Vaccine; Feline Panleukopenia (FPV) Vaccine
2) By Inactivated: Inactivated Feline Leukemia Virus (FeLV) Vaccine; Inactivated Feline Infectious Peritonitis (FIP) Vaccine
3) By Other Vaccine Types: Recombinant Vaccines; DNA Vaccines; Subunit Vaccines; Combination Vaccines
Companies Mentioned: Merck & Co. Inc.; Boehringer Ingelheim International GmbH; Zoetis Inc.; MSD Animal Health; Elanco Animal Health Incorporated
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r33456

1. Executive Summary

2. Cat Vaccine Market Characteristics

3. Cat Vaccine Market Trends And Strategies

4. Cat Vaccine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Cat Vaccine Growth Analysis And Strategic Analysis Framework

5.1. Global Cat Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Cat Vaccine Market Growth Rate Analysis
5.4. Global Cat Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Cat Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Cat Vaccine Total Addressable Market (TAM)

6. Cat Vaccine Market Segmentation

6.1. Global Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Modified Or Attenuated Live
Inactivated
Other Vaccine Types
6.2. Global Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Feline Leukemia
Feline Panleukopenia
Feline Respiratory Diseases
Feline Rabies
Other Diseases
6.3. Global Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Attenuated Live Vaccines
Conjugate Vaccines
Inactivated Vaccines
Subunit Vaccines
Toxoid Vaccines
Deoxyribonucleic Acid (DNA) Vaccines
Recombinant Vaccines
6.4. Global Cat Vaccine Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injectables
Intranasal
Oral
6.5. Global Cat Vaccine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Veterinary Clinics
Pet Stores
Online Retailers
6.6. Global Cat Vaccine Market, Sub-Segmentation Of Modified or Attenuated Live, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Feline Viral Rhinotracheitis (FVR) Vaccine
Feline Calicivirus (FCV) Vaccine
Feline Panleukopenia (FPV) Vaccine
6.7. Global Cat Vaccine Market, Sub-Segmentation Of Inactivated, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inactivated Feline Leukemia Virus (FeLV) Vaccine
Inactivated Feline Infectious Peritonitis (FIP) Vaccine
6.8. Global Cat Vaccine Market, Sub-Segmentation Of Other Vaccine Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Recombinant Vaccines
DNA Vaccines
Subunit Vaccines
Combination Vaccines

7. Cat Vaccine Market Regional And Country Analysis

7.1. Global Cat Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Cat Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cat Vaccine Market

8.1. Asia-Pacific Cat Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cat Vaccine Market

9.1. China Cat Vaccine Market Overview
9.2. China Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cat Vaccine Market

10.1. India Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cat Vaccine Market

11.1. Japan Cat Vaccine Market Overview
11.2. Japan Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cat Vaccine Market

12.1. Australia Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cat Vaccine Market

13.1. Indonesia Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cat Vaccine Market

14.1. South Korea Cat Vaccine Market Overview
14.2. South Korea Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cat Vaccine Market

15.1. Western Europe Cat Vaccine Market Overview
15.2. Western Europe Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cat Vaccine Market

16.1. UK Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cat Vaccine Market

17.1. Germany Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cat Vaccine Market

18.1. France Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cat Vaccine Market

19.1. Italy Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cat Vaccine Market

20.1. Spain Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cat Vaccine Market

21.1. Eastern Europe Cat Vaccine Market Overview
21.2. Eastern Europe Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cat Vaccine Market

22.1. Russia Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cat Vaccine Market

23.1. North America Cat Vaccine Market Overview
23.2. North America Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cat Vaccine Market

24.1. USA Cat Vaccine Market Overview
24.2. USA Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cat Vaccine Market

25.1. Canada Cat Vaccine Market Overview
25.2. Canada Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cat Vaccine Market

26.1. South America Cat Vaccine Market Overview
26.2. South America Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cat Vaccine Market

27.1. Brazil Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cat Vaccine Market

28.1. Middle East Cat Vaccine Market Overview
28.2. Middle East Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cat Vaccine Market

29.1. Africa Cat Vaccine Market Overview
29.2. Africa Cat Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Cat Vaccine Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Cat Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cat Vaccine Market Competitive Landscape And Company Profiles

30.1. Cat Vaccine Market Competitive Landscape
30.2. Cat Vaccine Market Company Profiles
- 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. MSD Animal Health Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Elanco Animal Health Incorporated Overview, Products and Services, Strategy and Financial Analysis

31. Cat Vaccine Market Other Major And Innovative Companies

31.1. Intas Pharmaceuticals Ltd.
31.2. Ceva Sante Animale
31.3. Virbac
31.4. Neogen Corporation
31.5. Indian Immunologicals Ltd.
31.6. Jinyu Bio-technology Co. Ltd.
31.7. Ourofino Animal Health SA
31.8. Biogenesis Bago SA
31.9. Valley Vet Supply
31.10. HIPRA Corporation
31.11. Bioveta AS
31.12. China Animal Husbandry Group
31.13. Veterinary Pharmaceutical Solutions
31.14. Torigen Pharmaceuticals Inc.
31.15. KM Vet Pharm Sdn Bhd.

32. Global Cat Vaccine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cat Vaccine Market

34. Recent Developments In The Cat Vaccine Market

35. Cat Vaccine Market High Potential Countries, Segments and Strategies

35.1 Cat Vaccine Market In 2029 - Countries Offering Most New Opportunities
35.2 Cat Vaccine Market In 2029 - Segments Offering Most New Opportunities
35.3 Cat Vaccine Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
250423_r33456_Cat_Vaccine_GMR_2025